[go: up one dir, main page]

SMT201400187B - Il-6 and receptor of humanized IL-6 - Google Patents

Il-6 and receptor of humanized IL-6

Info

Publication number
SMT201400187B
SMT201400187B SM201400187T SM201400187T SMT201400187B SM T201400187 B SMT201400187 B SM T201400187B SM 201400187 T SM201400187 T SM 201400187T SM 201400187 T SM201400187 T SM 201400187T SM T201400187 B SMT201400187 B SM T201400187B
Authority
SM
San Marino
Prior art keywords
humanized
receptor
Prior art date
Application number
SM201400187T
Other languages
Italian (it)
Inventor
Li-Hsien Wang
Anthony T Dore
Sean Stevens
Andrew J Murphy
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SMT201400187B publication Critical patent/SMT201400187B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SM201400187T 2011-10-28 2014-12-15 Il-6 and receptor of humanized IL-6 SMT201400187B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161552900P 2011-10-28 2011-10-28
US201161556579P 2011-11-07 2011-11-07
PCT/US2012/062379 WO2013063556A1 (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor

Publications (1)

Publication Number Publication Date
SMT201400187B true SMT201400187B (en) 2015-01-15

Family

ID=47295138

Family Applications (2)

Application Number Title Priority Date Filing Date
SM20170222T SMT201700222T1 (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor
SM201400187T SMT201400187B (en) 2011-10-28 2014-12-15 Il-6 and receptor of humanized IL-6

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SM20170222T SMT201700222T1 (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor

Country Status (27)

Country Link
US (10) US8878001B2 (en)
EP (2) EP2663575B1 (en)
JP (2) JP6120451B2 (en)
KR (2) KR102084927B1 (en)
CN (2) CN108866101A (en)
AU (1) AU2015207889B2 (en)
BR (1) BR112014008529A2 (en)
CA (1) CA2853731C (en)
CY (2) CY1116614T1 (en)
DK (2) DK2663575T3 (en)
ES (2) ES2525368T3 (en)
HR (2) HRP20141192T1 (en)
HU (1) HUE033400T2 (en)
IL (4) IL231896B (en)
IN (1) IN2014CN03920A (en)
LT (1) LT2818478T (en)
MX (1) MX358390B (en)
MY (2) MY186903A (en)
PL (2) PL2663575T3 (en)
PT (2) PT2663575E (en)
RS (2) RS53683B1 (en)
RU (2) RU2634417C2 (en)
SG (3) SG10202100485XA (en)
SI (2) SI2818478T1 (en)
SM (2) SMT201700222T1 (en)
WO (1) WO2013063556A1 (en)
ZA (1) ZA201402635B (en)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3010323T3 (en) 2009-10-06 2025-04-02 Regeneron Pharma Genetically modified mice and engraftment
KR102714361B1 (en) 2011-02-15 2024-10-11 리제너론 파마슈티칼스 인코포레이티드 Humanized m-csf mice
PL2663575T3 (en) 2011-10-28 2015-03-31 Regeneron Pharma Humanized il-6 and il-6 receptor
US20130261016A1 (en) * 2012-03-28 2013-10-03 Meso Scale Technologies, Llc Diagnostic methods for inflammatory disorders
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
KR102473555B1 (en) 2012-09-07 2022-12-05 예일 유니버시티 Genetically modified non-human animals and methods of use thereof
WO2014042251A1 (en) * 2012-09-13 2014-03-20 中外製薬株式会社 Gene knock-in non-human animal
IL311744B2 (en) * 2012-11-05 2025-10-01 Regeneron Pharma Genetically modified non-human animals and methods of use thereof
LT2958938T (en) 2013-02-20 2019-07-25 Regeneron Pharmaceuticals, Inc. MOUSE EXPRESSING HUMANIZED T-CELL CORECEPTORS
EP2958937B1 (en) 2013-02-22 2018-08-15 Regeneron Pharmaceuticals, Inc. Mice expressing humanized major histocompatibility complex
GB2513884B (en) 2013-05-08 2015-06-17 Univ Bristol Method and apparatus for producing an acoustic field
PT4269430T (en) * 2013-09-23 2025-08-06 Regeneron Pharma Non-human animals having a humanized signal-regulatory protein gene
EP3138397B1 (en) * 2013-10-15 2018-12-26 Regeneron Pharmaceuticals, Inc. Humanized il-15 animals
MX356809B (en) 2013-11-19 2018-06-13 Regeneron Pharma Non-human animals having a humanized b-cell activating factor gene.
EP3071025B1 (en) * 2013-11-19 2018-10-10 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized a proliferation-inducing ligand gene
US9612658B2 (en) 2014-01-07 2017-04-04 Ultrahaptics Ip Ltd Method and apparatus for providing tactile sensations
CA2934965A1 (en) 2014-01-31 2016-03-17 Boehringer Ingelheim International Gmbh Novel anti-baff antibodies
RU2700484C2 (en) 2014-04-08 2019-09-17 Регенерон Фармасьютикалз, Инк. NON-HUMAN ANIMALS HAVING HUMANIZED Fc-γ-RECEPTORS
MX2016014504A (en) 2014-05-05 2017-05-23 Regeneron Pharma Humanized c5 and c3 animals.
NO2785538T3 (en) * 2014-05-07 2018-08-04
KR20250096864A (en) 2014-05-19 2025-06-27 리제너론 파마슈티칼스 인코포레이티드 Genetically modified non-human animals expressing human epo
US9497945B2 (en) 2014-05-30 2016-11-22 Regeneron Pharmaceuticals, Inc. Humanized dipeptidyl peptidase IV (DPP4) animals
CN106604635B (en) * 2014-06-19 2020-01-14 瑞泽恩制药公司 Non-human animal having humanized programmed cell death 1 gene
GB2530036A (en) 2014-09-09 2016-03-16 Ultrahaptics Ltd Method and apparatus for modulating haptic feedback
DK3223605T3 (en) 2014-11-24 2020-11-16 Regeneron Pharma NON-HUMAN ANIMALS EXPRESSING HUMANIZED CD3 COMPLEX
EP3086637B1 (en) * 2014-12-05 2019-01-02 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cluster of differentiation 47 gene
MX2017007636A (en) 2014-12-09 2018-03-28 Regeneron Pharma Non-human animals having a humanized cluster of differentiation 274 gene.
KR102515997B1 (en) 2015-02-20 2023-03-29 울트라햅틱스 아이피 엘티디 Perception in haptic systems
ES2908299T3 (en) 2015-02-20 2022-04-28 Ultrahaptics Ip Ltd Algorithm improvements in a haptic system
KR20240132525A (en) 2015-04-06 2024-09-03 리제너론 파아마슈티컬스, 인크. Humanized t cell mediated immune responses in non-human animals
CN107896479B (en) 2015-04-13 2021-07-13 再生元制药公司 Humanized SIRPα-IL15 knock-in mice and methods of use
US10818162B2 (en) 2015-07-16 2020-10-27 Ultrahaptics Ip Ltd Calibration techniques in haptic systems
AU2016358101B2 (en) 2015-11-20 2022-12-01 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized Lymphocyte-activation gene 3
KR102851747B1 (en) 2015-12-08 2025-08-28 리제너론 파마슈티칼스 인코포레이티드 Enzyme internalization composition and method
US11189140B2 (en) 2016-01-05 2021-11-30 Ultrahaptics Ip Ltd Calibration and detection techniques in haptic systems
KR102487839B1 (en) 2016-02-04 2023-01-12 리제너론 파마슈티칼스 인코포레이티드 Non-human animals with an engineered ANGPTL8 gene
SG10202001578RA (en) 2016-02-29 2020-04-29 Regeneron Pharma Rodents having a humanized tmprss gene
CN109640644B (en) 2016-06-03 2021-10-26 瑞泽恩制药公司 Non-human animals expressing exogenous terminal deoxynucleotidyl transferase
US10531212B2 (en) 2016-06-17 2020-01-07 Ultrahaptics Ip Ltd. Acoustic transducers in haptic systems
US10268275B2 (en) 2016-08-03 2019-04-23 Ultrahaptics Ip Ltd Three-dimensional perceptions in haptic systems
US10755538B2 (en) 2016-08-09 2020-08-25 Ultrahaptics ilP LTD Metamaterials and acoustic lenses in haptic systems
CN107815467B (en) * 2016-08-31 2021-03-16 百奥赛图(北京)医药科技股份有限公司 Preparation method and application of humanized gene modified animal model
US10943578B2 (en) 2016-12-13 2021-03-09 Ultrahaptics Ip Ltd Driving techniques for phased-array systems
US10497358B2 (en) 2016-12-23 2019-12-03 Ultrahaptics Ip Ltd Transducer driver
CN108467873B (en) 2017-03-17 2020-03-13 百奥赛图江苏基因生物技术有限公司 Preparation method and application of CD132 gene-deleted immunodeficiency animal model
WO2018177441A1 (en) 2017-03-31 2018-10-04 Beijing Biocytogen Co., Ltd GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα
CN108588126B (en) 2017-03-31 2020-04-10 北京百奥赛图基因生物技术有限公司 Preparation method and application of humanized modified animal model of CD47 gene
EP3585162B1 (en) 2017-09-29 2023-08-30 Regeneron Pharmaceuticals, Inc. Rodents comprising a humanized ttr locus and methods of use
US11531395B2 (en) 2017-11-26 2022-12-20 Ultrahaptics Ip Ltd Haptic effects from focused acoustic fields
CA3076377A1 (en) 2017-11-30 2019-06-06 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized trkb locus
WO2019122912A1 (en) 2017-12-22 2019-06-27 Ultrahaptics Limited Tracking in haptic systems
EP3729418B1 (en) 2017-12-22 2024-11-20 Ultrahaptics Ip Ltd Minimizing unwanted responses in haptic systems
CA3093850A1 (en) 2018-03-26 2019-10-03 Regeneron Pharmaceuticals, Inc. Humanized rodents for testing therapeutic agents
WO2019211616A1 (en) 2018-05-02 2019-11-07 Ultrahaptics Limited Blocking plate structure for improved acoustic transmission efficiency
SMT202400300T1 (en) * 2018-07-16 2024-09-16 Regeneron Pharma Rodent models of ditra disease and uses thereof
US11098951B2 (en) 2018-09-09 2021-08-24 Ultrahaptics Ip Ltd Ultrasonic-assisted liquid manipulation
US11378997B2 (en) 2018-10-12 2022-07-05 Ultrahaptics Ip Ltd Variable phase and frequency pulse-width modulation technique
WO2020125639A1 (en) * 2018-12-17 2020-06-25 Biocytogen Jiangsu Co., Ltd. Genetically modified non-human animal with human or chimeric genes
US12373033B2 (en) 2019-01-04 2025-07-29 Ultrahaptics Ip Ltd Mid-air haptic textures
WO2020141330A2 (en) 2019-01-04 2020-07-09 Ultrahaptics Ip Ltd Mid-air haptic textures
CN111218425B (en) * 2019-01-17 2022-02-08 百奥赛图(北京)医药科技股份有限公司 Humanized transgenic animal
CN117178959A (en) 2019-04-04 2023-12-08 瑞泽恩制药公司 Non-human animals including the humanized coagulation factor 12 locus
US11842517B2 (en) 2019-04-12 2023-12-12 Ultrahaptics Ip Ltd Using iterative 3D-model fitting for domain adaptation of a hand-pose-estimation neural network
US20220340926A1 (en) * 2019-05-27 2022-10-27 Transgenic Inc. Exon-humanized mouse
AU2020286382A1 (en) 2019-06-04 2021-11-04 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized TTR locus with a beta-slip mutation and methods of use
MX2021015122A (en) 2019-06-07 2022-04-06 Regeneron Pharma NON-HUMAN ANIMALS COMPRISING A HUMANIZED ALBUMIN LOCUS.
US11374586B2 (en) 2019-10-13 2022-06-28 Ultraleap Limited Reducing harmonic distortion by dithering
CA3154040A1 (en) 2019-10-13 2021-04-22 Benjamin John Oliver LONG Dynamic capping with virtual microphones
WO2021090028A1 (en) 2019-11-08 2021-05-14 Ultraleap Limited Tracking techniques in haptics systems
CN111304246B (en) * 2019-12-17 2021-05-04 百奥赛图江苏基因生物技术有限公司 Humanized cytokine animal model, preparation method and application
US11715453B2 (en) 2019-12-25 2023-08-01 Ultraleap Limited Acoustic transducer structures
WO2021154791A1 (en) * 2020-01-28 2021-08-05 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized pnpla3 locus and methods of use
AU2021261267A1 (en) 2020-04-21 2022-09-08 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized Cxcl13 gene
US11816267B2 (en) 2020-06-23 2023-11-14 Ultraleap Limited Features of airborne ultrasonic fields
US11886639B2 (en) 2020-09-17 2024-01-30 Ultraleap Limited Ultrahapticons
CN118511853A (en) 2021-03-31 2024-08-20 瑞泽恩制药公司 Genetically modified mice comprising humanized cellular immune system components with improved TCRB repertoire diversity
US20240224964A9 (en) 2022-09-29 2024-07-11 Regeneron Pharmaceuticals, Inc. Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 signaling in human hepatocytes
WO2025212991A1 (en) 2024-04-05 2025-10-09 Regeneron Pharmaceuticals, Inc. Rodent models of disease
WO2025250495A1 (en) 2024-05-28 2025-12-04 Regeneron Pharmaceuticals, Inc. Acceleration of human hepatocyte engraftment in humanized liver animals by supplementing paracrine ligands or agonists that activate human liver regeneration signals

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0786007A1 (en) * 1994-10-14 1997-07-30 Basf Aktiengesellschaft Transgenic nonhuman animal having functionally disrupted interleukin-1-beta converting enzyme gene
EP1884524A3 (en) 1994-10-21 2008-06-25 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for treatment of diseases caused by IL-6 production
US20030082721A1 (en) * 2001-01-17 2003-05-01 Tai-Jay Chang Transgenic animals expressing androgen receptor complex-associated protein
CN1560081A (en) * 2004-02-17 2005-01-05 大连帝恩生物工程有限公司 Preparing human source monoclone antibody by mouse capable of producing human IgGl weight chain-k light chain and application thereof
PL2767161T3 (en) 2004-10-19 2018-09-28 Regeneron Pharmaceuticals, Inc. Method for generating an non-human animal homozygous for a genetic modification
US7759541B2 (en) * 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
GB2434578A (en) 2006-01-26 2007-08-01 Univ Basel Transgenic animals
PL2374818T3 (en) 2006-06-02 2013-05-31 Regeneron Pharma High affinity antibodies to human IL-6 receptor
CA2661848C (en) * 2006-09-01 2015-02-03 Therapeutic Human Polyclonals, Inc. Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
FR2942218A1 (en) 2009-02-13 2010-08-20 Eurocave Sa APPARATUS FOR SERVING GLASS OF A LIQUID, IN PARTICULAR WINE
ES3010323T3 (en) * 2009-10-06 2025-04-02 Regeneron Pharma Genetically modified mice and engraftment
JP5595517B2 (en) * 2009-12-21 2014-09-24 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Humanized FcγR mouse
KR102714361B1 (en) 2011-02-15 2024-10-11 리제너론 파마슈티칼스 인코포레이티드 Humanized m-csf mice
TWI681970B (en) 2011-09-30 2020-01-11 日商中外製藥股份有限公司 An antigen-binding molecule comprising an antigen-binding domain whose binding activity to an antigen is changed according to the ion concentration condition, and an FcRn-binding domain having binding activity to FcRn under pH-neutral conditions, and which induces an immune response against the target antigen
DK2770821T3 (en) 2011-10-28 2017-11-27 Regeneron Pharma GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MOUSE
PL2663575T3 (en) 2011-10-28 2015-03-31 Regeneron Pharma Humanized il-6 and il-6 receptor
KR101926442B1 (en) 2011-10-28 2018-12-12 리제너론 파아마슈티컬스, 인크. Genetically modified mice expressing chimeric major histocompatibility complex (mhc) ii molecules

Also Published As

Publication number Publication date
AU2015207889A1 (en) 2015-08-20
RU2014121324A (en) 2015-12-10
SI2663575T1 (en) 2015-01-30
MX2014004900A (en) 2014-08-26
CY1118952T1 (en) 2018-01-10
KR102084927B1 (en) 2020-03-06
US20150013022A1 (en) 2015-01-08
US20250287931A1 (en) 2025-09-18
US10433528B2 (en) 2019-10-08
LT2818478T (en) 2017-06-12
ZA201402635B (en) 2015-09-30
RS55949B1 (en) 2017-09-29
MY186903A (en) 2021-08-26
DK2818478T3 (en) 2017-05-22
AU2015207889B2 (en) 2017-02-23
SG11201400945UA (en) 2014-04-28
US11102962B2 (en) 2021-08-31
KR20140091024A (en) 2014-07-18
CY1116614T1 (en) 2017-03-15
EP2818478A1 (en) 2014-12-31
WO2013063556A8 (en) 2014-04-17
JP2014532416A (en) 2014-12-08
US20200008407A1 (en) 2020-01-09
IL243665B (en) 2018-02-28
RU2017129763A3 (en) 2020-12-18
HK1205135A1 (en) 2015-12-11
US10004211B2 (en) 2018-06-26
US9622460B2 (en) 2017-04-18
ES2624605T3 (en) 2017-07-17
CN104039821A (en) 2014-09-10
SG10201600965YA (en) 2016-03-30
IL231896B (en) 2018-02-28
US20130117873A1 (en) 2013-05-09
SG10202100485XA (en) 2021-02-25
US20150272092A1 (en) 2015-10-01
NZ709432A (en) 2015-12-24
US20170055506A1 (en) 2017-03-02
US20160278352A1 (en) 2016-09-29
US9078418B2 (en) 2015-07-14
CA2853731C (en) 2021-05-18
US20150013023A1 (en) 2015-01-08
SMT201700222T1 (en) 2017-07-18
JP2017035115A (en) 2017-02-16
IL243666B (en) 2019-02-28
EP2818478B1 (en) 2017-02-01
RU2017129763A (en) 2019-02-05
PT2663575E (en) 2014-12-05
IN2014CN03920A (en) 2015-09-04
ES2525368T3 (en) 2014-12-23
BR112014008529A2 (en) 2017-04-18
RU2751240C2 (en) 2021-07-12
DK2663575T3 (en) 2014-12-15
PT2818478T (en) 2017-05-12
US8878001B2 (en) 2014-11-04
EP2663575B1 (en) 2014-10-01
US20220053742A1 (en) 2022-02-24
IL243666A0 (en) 2016-03-31
US9125386B2 (en) 2015-09-08
KR102234632B1 (en) 2021-04-02
KR20200024949A (en) 2020-03-09
HK1190408A1 (en) 2014-07-04
WO2013063556A4 (en) 2013-06-20
RU2634417C2 (en) 2017-10-26
IL243665A0 (en) 2016-03-31
US9392777B2 (en) 2016-07-19
EP2663575A1 (en) 2013-11-20
US12239111B2 (en) 2025-03-04
WO2013063556A1 (en) 2013-05-02
IL264508A (en) 2019-02-28
NZ623145A (en) 2015-09-25
SI2818478T1 (en) 2017-07-31
PL2663575T3 (en) 2015-03-31
US20180271071A1 (en) 2018-09-27
JP6120451B2 (en) 2017-04-26
HRP20170656T1 (en) 2017-06-30
HRP20141192T1 (en) 2015-02-13
IL231896A0 (en) 2014-05-28
CN108866101A (en) 2018-11-23
RS53683B1 (en) 2015-04-30
IL264508B (en) 2019-12-31
MX358390B (en) 2018-08-17
CA2853731A1 (en) 2013-05-02
MY172726A (en) 2019-12-11
PL2818478T3 (en) 2017-09-29
HUE033400T2 (en) 2017-12-28

Similar Documents

Publication Publication Date Title
SMT201400187B (en) Il-6 and receptor of humanized IL-6
PL3415531T3 (en) ANTIGEN-BINDING PROTEINS
DK2521736T3 (en) Humanized antibodies
EP3418306C0 (en) IMPROVED ASSEMBLY OF BISPECIFIC ANTIBODIES
DK3653645T3 (en) Monoclonal interleukin-31 antibody
EP2683693A4 (en) INHIBITORS OF RORGAMMAT
CO6811812A2 (en) Anti-b7-h3 antibody
SMT201600150B (en) ANTAGONISTS OF TRPV4
CR20140127A (en) ANTI-ABTCR ANTIBODY
BR112014003878A2 (en) synthesis of r-biphenylalaninol
DK2733803T4 (en) SECTION OF CABLE BACK
EP2691361A4 (en) SYNTHESIS OF DIACIDES
BR112014004742A2 (en) trough
GB201121564D0 (en) Use of antibody
EP2755663A4 (en) INHIBITORS OF MICRO-ARNMICRORNA INHIBITORS
EP2804607A4 (en) SYNTHESIS OF RALREGRAVIR
PL394955A1 (en) Element of building construction
UA22462S (en) DETAIL OF SHAPED COMPRESSION-FLANGE
UA22461S (en) DETAIL OF SHAPED COMPRESSION-COLLECTING
ES1075983Y (en) CONTAINER-DISPENSER OF APPETIZERS
ES1075437Y (en) CLEANING ELEMENTS OF CLEANING ELEMENTS
UA22930S (en) BLOCK OF FIXED FORMWORK
DK2797952T3 (en) Method of providing monoclonal autoantibodies with desired specificity
UA22157S (en) SET OF DRINKS
UA22428S (en) PLUMBING PLUMBING